BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 9836013)

  • 1. Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography.
    Malison RT; Price LH; Berman R; van Dyck CH; Pelton GH; Carpenter L; Sanacora G; Owens MJ; Nemeroff CB; Rajeevan N; Baldwin RM; Seibyl JP; Innis RB; Charney DS
    Biol Psychiatry; 1998 Dec; 44(11):1090-8. PubMed ID: 9836013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central serotonin transporter availability measured with [123I]beta-CIT SPECT in relation to serotonin transporter genotype.
    van Dyck CH; Malison RT; Staley JK; Jacobsen LK; Seibyl JP; Laruelle M; Baldwin RM; Innis RB; Gelernter J
    Am J Psychiatry; 2004 Mar; 161(3):525-31. PubMed ID: 14992979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.
    Pirker W; Asenbaum S; Hauk M; Kandlhofer S; Tauscher J; Willeit M; Neumeister A; Praschak-Rieder N; Angelberger P; Brücke T
    J Nucl Med; 2000 Jan; 41(1):36-44. PubMed ID: 10647603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related decline in central serotonin transporter availability with [(123)I]beta-CIT SPECT.
    van Dyck CH; Malison RT; Seibyl JP; Laruelle M; Klumpp H; Zoghbi SS; Baldwin RM; Innis RB
    Neurobiol Aging; 2000; 21(4):497-501. PubMed ID: 10924762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.
    Staley JK; Krishnan-Sarin S; Zoghbi S; Tamagnan G; Fujita M; Seibyl JP; Maciejewski PK; O'Malley S; Innis RB
    Synapse; 2001 Sep; 41(4):275-84. PubMed ID: 11494398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of [123I]beta-CIT and [123I]IPCIT as single-photon emission tomography radiotracers for the dopamine transporter in nonhuman primates.
    Scanley BE; al-Tikriti MS; Gandelman MS; Laruelle M; Zea-Ponce Y; Baldwin RM; Zoghbi SS; Hoffer PB; Charney DS; Wang S
    Eur J Nucl Med; 1995 Jan; 22(1):4-11. PubMed ID: 7698153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional serotonin transporter availability and depression are correlated in Wilson's disease.
    Hesse S; Barthel H; Hermann W; Murai T; Kluge R; Wagner A; Sabri O; Eggers B
    J Neural Transm (Vienna); 2003 Aug; 110(8):923-33. PubMed ID: 12898347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder.
    Pogarell O; Hamann C; Pöpperl G; Juckel G; Choukèr M; Zaudig M; Riedel M; Möller HJ; Hegerl U; Tatsch K
    Biol Psychiatry; 2003 Dec; 54(12):1406-13. PubMed ID: 14675805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT.
    Abi-Dargham A; Gandelman MS; DeErausquin GA; Zea-Ponce Y; Zoghbi SS; Baldwin RM; Laruelle M; Charney DS; Hoffer PB; Neumeyer JL; Innis RB
    J Nucl Med; 1996 Jul; 37(7):1129-33. PubMed ID: 8965183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [123I] beta-CIT, a tracer for dopamine and serotonin re-uptake sites: preparation and preliminary SPECT studies in humans.
    Bergström KA; Kuikka JT; Ahonen A; Vanninen E
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):128-31. PubMed ID: 7632756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [123I]-beta-CIT SPECT imaging shows reduced thalamus-hypothalamus serotonin transporter availability in 24 drug-free obsessive-compulsive checkers.
    Zitterl W; Aigner M; Stompe T; Zitterl-Eglseer K; Gutierrez-Lobos K; Schmidl-Mohl B; Wenzel T; Demal U; Zettinig G; Hornik K; Thau K
    Neuropsychopharmacology; 2007 Aug; 32(8):1661-8. PubMed ID: 17192774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors.
    Kugaya A; Sanacora G; Staley JK; Malison RT; Bozkurt A; Khan S; Anand A; Van Dyck CH; Baldwin RM; Seibyl JP; Charney D; Innis RB
    Biol Psychiatry; 2004 Oct; 56(7):497-502. PubMed ID: 15450785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder.
    Willeit M; Praschak-Rieder N; Neumeister A; Pirker W; Asenbaum S; Vitouch O; Tauscher J; Hilger E; Stastny J; Brücke T; Kasper S
    Biol Psychiatry; 2000 Mar; 47(6):482-9. PubMed ID: 10715354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the monoamine uptake site ligand [123I]methyl 3 beta-(4-iodophenyl)-tropane-2 beta-carboxylate ([123I]beta-CIT) in non-human primates: pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI.
    Baldwin RM; Zea-Ponce Y; Zoghbi SS; Laurelle M; al-Tikriti MS; Sybirska EH; Malison RT; Neumeyer JL; Milius RA; Wang S
    Nucl Med Biol; 1993 Jul; 20(5):597-606. PubMed ID: 8358345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of iodine-123 labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and 2 beta-carbomethoxy-3 beta-(4-iodophenyl)-N-(3-fluoropropyl)nortropane for imaging of the dopamine transporter in the living human brain.
    Kuikka JT; Bergström KA; Ahonen A; Hiltunen J; Haukka J; Länsimies E; Wang S; Neumeyer JL
    Eur J Nucl Med; 1995 Apr; 22(4):356-60. PubMed ID: 7607268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I-beta-CIT SPECT.
    Kim SE; Choi JY; Choe YS; Choi Y; Lee WY
    J Nucl Med; 2003 Jun; 44(6):870-6. PubMed ID: 12791812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients.
    Jacobsen LK; Staley JK; Malison RT; Zoghbi SS; Seibyl JP; Kosten TR; Innis RB
    Am J Psychiatry; 2000 Jul; 157(7):1134-40. PubMed ID: 10873923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Euphorigenic doses of cocaine reduce [123I]beta-CIT SPECT measures of dopamine transporter availability in human cocaine addicts.
    Malison RT; Best SE; Wallace EA; McCance E; Laruelle M; Zoghbi SS; Baldwin RM; Seibyl JS; Hoffer PB; Price LH
    Psychopharmacology (Berl); 1995 Dec; 122(4):358-62. PubMed ID: 8657833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodine-123 labeled nor-beta-CIT as a potential tracer for serotonin transporter imaging in the human brain with single-photon emission tomography.
    Hiltunen J; Akerman KK; Kuikka JT; Bergström KA; Halldin C; Nikula T; Räsänen P; Tiihonen J; Vauhkonen M; Karhu J; Kupila J; Länsimies E; Farde L
    Eur J Nucl Med; 1998 Jan; 25(1):19-23. PubMed ID: 9396870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced central serotonin transporters in alcoholism.
    Heinz A; Ragan P; Jones DW; Hommer D; Williams W; Knable MB; Gorey JG; Doty L; Geyer C; Lee KS; Coppola R; Weinberger DR; Linnoila M
    Am J Psychiatry; 1998 Nov; 155(11):1544-9. PubMed ID: 9812115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.